- Forschung
- Karriere
- Aktuelles
- Institut
- Durchsuchen
- Spachumstellung
- Leichte Sprache
„”
Prof. Dr.
Ralf Schülein hat Biologie in Würzburg studiert und dort am Lehrstuhl für Mikrobiologie promoviert. Als Post-Doc arbeitete er für drei Jahre im Rudolf-Buchheim-Institut für Pharmakologie der Universität Gießen. Seit 1997 leitet er eine Forschungsgruppe am FMP, seit 2020 die Cell Engineering Facility. Die Habilitation im Fach Pharmakologie und Toxikologie erfolgte an der ehemaligen Fakultät für Medizin der Freien Universität Berlin. Im Jahr 2014 wurde Ralf Schülein zum außerplanmäßigen Professor an der Charite-Universitätsmedizin Berlin ernannt. Er unterrichtet dort MedizinstudentInnen im Fach Pharmakologie und Toxikologie. Ferner hat er einen Lehrauftrag an der Freien Universität Berlin.
Molekulare Physiologie & Zellbiologie
Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway
International journal of molecular sciences 2021
online lesenA Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide
Molecular & cellular proteomics : MCP 2021
online lesenModulating TSH Receptor Signaling for Therapeutic Benefit
European thyroid journal 2020
online lesenCharacterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation
Scientific reports 2020
online lesenA New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy
Thyroid : official journal of the American Thyroid Association 2019
online lesenThyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain
Molecular pharmacology 2019
online lesenEvidence of G-protein-coupled receptor and substrate transporter heteromerization at a single molecule level
Cellular and molecular life sciences : CMLS 2018
online lesenUse of a sequential high throughput screening assay to identify novel inhibitors of the eukaryotic SRP-Sec61 targeting/translocation pathway
PloS one 2018
online lesenEvidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS
Hypertension (Dallas, Tex. : 1979) 2017
online lesenTargeting G Protein-Coupled Receptors by Capture Compound Mass Spectrometry: A Case Study with Sertindole
Chembiochem : a European journal of chemical biology 2017
online lesenFunctional Significance of the Signal Peptides of Corticotropin-Releasing Factor Receptors
Current molecular pharmacology 2017
online lesenDefining a conformational consensus motif in cotransin-sensitive signal sequences: a proteomic and site-directed mutagenesis study
PloS one 2015
online lesenA new variant in signal peptide of the human luteinizing hormone receptor (LHCGR) affects receptor biogenesis causing leydig cell hypoplasia
Human molecular genetics 2015
online lesenInvolvement of the L-Type Amino Acid Transporter Lat2 in the Transport of 3,3'-Diiodothyronine across the Plasma Membrane
European thyroid journal 2015
online lesenN-Terminal Signal Peptides of G Protein-Coupled Receptors: Significance for Receptor Biosynthesis, Trafficking, and Signal Transduction
Progress in molecular biology and translational science 2015
online lesenStructural insights into thyroid hormone transport mechanisms of the L-type amino acid transporter 2
Molecular endocrinology (Baltimore, Md.) 2015
online lesenThe specific monomer/dimer equilibrium of the corticotropin-releasing factor receptor type 1 is established in the endoplasmic reticulum
The Journal of biological chemistry 2014
online lesenDifferences between lutropin-mediated and choriogonadotropin-mediated receptor activation
The FEBS journal 2014
online lesenUse of Kaede and Kikume green-red fusions for live cell imaging of G protein-coupled receptors
Methods in molecular biology (Clifton, N.J.) 2014
online lesenThe Pseudo signal peptide of the corticotropin-releasing factor receptor type 2A prevents receptor oligomerization
The Journal of biological chemistry 2012
online lesenThe protease-activated receptor 1 possesses a functional and cleavable signal peptide which is necessary for receptor expression
FEBS letters 2012
online lesenLive cell imaging of G protein-coupled receptors
Methods in molecular biology (Clifton, N.J.) 2012
online lesenUse of Kikume green-red fusions to study the influence of pharmacological chaperones on trafficking of G protein-coupled receptors
FEBS letters 2012
online lesenFunctional significance of cleavable signal peptides of G protein-coupled receptors
European journal of cell biology 2012
online lesenThe proteoglycan syndecan 4 regulates transient receptor potential canonical 6 channels via RhoA/Rho-associated protein kinase signaling
Arteriosclerosis, thrombosis, and vascular biology 2012
online lesenInhibition of biosynthesis of human endothelin B receptor by the cyclodepsipeptide cotransin
The Journal of biological chemistry 2011
online lesenMutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor
Cellular and molecular life sciences : CMLS 2011
online lesenFrom molecular details of the interplay between transmembrane helices of the thyrotropin receptor to general aspects of signal transduction in family a G-protein-coupled receptors (GPCRs)
The Journal of biological chemistry 2011
online lesenPrimary and secondary thyroid hormone transporters
Thyroid research 2011
online lesenThe pseudo signal peptide of the corticotropin-releasing factor receptor type 2a decreases receptor expression and prevents Gi-mediated inhibition of adenylyl cyclase activity
The Journal of biological chemistry 2010
online lesenSignaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010
online lesenUse of Kaede fusions to visualize recycling of G protein-coupled receptors
Traffic (Copenhagen, Denmark) 2009
online lesenThe sequence after the signal peptide of the G protein-coupled endothelin B receptor is required for efficient translocon gating at the endoplasmic reticulum membrane
Molecular pharmacology 2009
online lesenThe corticotropin-releasing factor receptor type 2a contains an N-terminal pseudo signal peptide
The Journal of biological chemistry 2006
online lesenTIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression
Journal of immunology (Baltimore, Md. : 1950) 2006
online lesenThe signal peptide of the rat corticotropin-releasing factor receptor 1 promotes receptor expression but is not essential for establishing a functional receptor
The Biochemical journal 2005
online lesenThe role of N-glycosylation in the stability, trafficking and GABA-uptake of GABA-transporter 1. Terminal N-glycans facilitate efficient GABA-uptake activity of the GABA transporter
The FEBS journal 2005
online lesenThe hydrophobic amino acid residues in the membrane-proximal C tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding
FEBS letters 2005
online lesenA Ser/Thr cluster within the C-terminal domain of the rat prostaglandin receptor EP3alpha is essential for agonist-induced phosphorylation, desensitization and internalization
British journal of pharmacology 2005
online lesenIdentification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site
The Biochemical journal 2004
online lesenThe early stages of the intracellular transport of membrane proteins: clinical and pharmacological implications
Reviews of physiology, biochemistry and pharmacology 2004
online lesenPharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors
The Journal of biological chemistry 2004
online lesenDisease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway
Traffic (Copenhagen, Denmark) 2004
online lesenThe extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process
The Journal of biological chemistry 2002
online lesenThe signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane
The Journal of biological chemistry 2002
online lesenFunctional rescue of the nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutants G185C and R202C by a second site suppressor mutation
The Journal of biological chemistry 2001
online lesenSorting functions of the individual cytoplasmic domains of the G protein-coupled vasopressin V(2) receptor in Madin Darby canine kidney epithelial cells
Molecular pharmacology 2001
online lesenThe role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues
FEBS letters 2000
online lesenMolecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor
Molecular pharmacology 2000
online lesenA single negatively charged residue affects the orientation of a membrane protein in the inner membrane of Escherichia coli only when it is located adjacent to a transmembrane domain
The Journal of biological chemistry 1999
online lesenPolarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells
Kidney international 1999
online lesenFolding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus
FEBS letters 1998
online lesenPolarized cell surface expression of the green fluorescent protein-tagged vasopressin V2 receptor in Madin Darby canine kidney cells
FEBS letters 1998
online lesenA dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells
Molecular pharmacology 1998
online lesenPrevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein
Immunity 1998
online lesenMembrane targeting and determination of transmembrane topology of the human vasopressin V2 receptor
The Journal of biological chemistry 1996
online lesenVasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function
Molecular pharmacology 1996
online lesenProperties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site
The Biochemical journal 1996
online lesenIdentification and characterization of two functional domains of the hemolysin translocator protein HlyD
Molecular & general genetics : MGG 1994
online lesenTwo novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus
Biochemical and biophysical research communications 1994
online lesenDas Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) gehört zum Forschungsverbund Berlin e.V. (FVB), einem Zusammenschluss von sieben natur-, lebens- und umweltwissenschaftlichen Instituten in Berlin. Die Einrichtungen sind Mitglieder der Leibniz-Gemeinschaft.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Deutschland